All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
XS-0822-YF712 | Anti-Human MUC3A (XW-712) h(41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-712 | Mouse | scFv-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF713 | Anti-Human MUC3A (XW-713) h(41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-713 | Human | scFv-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF1632 | Anti-Human MUC3A (XW-712) h(CD28-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-712 | Mouse | scFv-CD28-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF1633 | Anti-Human MUC3A (XW-713) h(CD28-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-713 | Human | scFv-CD28-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF2552 | Anti-Human MUC3A (XW-712) h(CD28-41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-712 | Mouse | scFv-CD28-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF2553 | Anti-Human MUC3A (XW-713) h(CD28-41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-713 | Human | scFv-CD28-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF8596 | TS-Fluc Anti-Human MUC3A scFv (XW-712) CD28-CD3ζ CAR, pCDCAR1 | Human | XW-712 | Mouse | 7H-YB-Fluc-EF1a-scFv-CD28-CD3ζ | Lentiviral vector | |||
XS-0822-YF8597 | TS-Fluc Anti-Human MUC3A scFv (XW-713) CD28-CD3ζ CAR, pCDCAR1 | Human | XW-713 | Human | 7H-YB-Fluc-EF1a-scFv-CD28-CD3ζ | Lentiviral vector | |||
XS-0822-YF9005 | TS-Fluc Anti-Human MUC3A scFv (XW-712) 41BB-CD3ζ CAR, pCDCAR1 | Human | XW-712 | Mouse | 7H-YB-Fluc-EF1a-scFv-41BB-CD3ζ | Lentiviral vector | |||
XS-0822-YF9006 | TS-Fluc Anti-Human MUC3A scFv (XW-713) 41BB-CD3ζ CAR, pCDCAR1 | Human | XW-713 | Human | 7H-YB-Fluc-EF1a-scFv-41BB-CD3ζ | Lentiviral vector | |||
XS-0822-YF9414 | TS-Fluc Anti-Human MUC3A scFv (XW-712) CD28-41BB-CD3ζ CAR, pCDCAR1 | Human | XW-712 | Mouse | 7H-YB-Fluc-EF1a-scFv-CD28-41BB-CD3ζ | Lentiviral vector | |||
XS-0822-YF9415 | TS-Fluc Anti-Human MUC3A scFv (XW-713) CD28-41BB-CD3ζ CAR, pCDCAR1 | Human | XW-713 | Human | 7H-YB-Fluc-EF1a-scFv-CD28-41BB-CD3ζ | Lentiviral vector | |||
XS-0822-YF9823 | TS-IL15 SA Anti-Human MUC3A scFv (XW-712) CD28-CD3ζ CAR, pCDCAR1 | Human | XW-712 | Mouse | 7H-YB-IL15 SA-EF1a-scFv-CD28-CD3ζ | Lentiviral vector | |||
XS-0822-YF9824 | TS-IL15 SA Anti-Human MUC3A scFv (XW-713) CD28-CD3ζ CAR, pCDCAR1 | Human | XW-713 | Human | 7H-YB-IL15 SA-EF1a-scFv-CD28-CD3ζ | Lentiviral vector | |||
XS-0822-YF10232 | TS-IL15 SA Anti-Human MUC3A scFv (XW-712) 41BB-CD3ζ CAR, pCDCAR1 | Human | XW-712 | Mouse | 7H-YB-IL15 SA-EF1a-scFv-41BB-CD3ζ | Lentiviral vector | |||
XS-0822-YF10233 | TS-IL15 SA Anti-Human MUC3A scFv (XW-713) 41BB-CD3ζ CAR, pCDCAR1 | Human | XW-713 | Human | 7H-YB-IL15 SA-EF1a-scFv-41BB-CD3ζ | Lentiviral vector | |||
XS-0822-YF10641 | TS-IL15 SA Anti-Human MUC3A scFv (XW-712) CD28-41BB-CD3ζ CAR, pCDCAR1 | Human | XW-712 | Mouse | 7H-YB-IL15 SA-EF1a-scFv-CD28-41BB-CD3ζ | Lentiviral vector | |||
XS-0822-YF10642 | TS-IL15 SA Anti-Human MUC3A scFv (XW-713) CD28-41BB-CD3ζ CAR, pCDCAR1 | Human | XW-713 | Human | 7H-YB-IL15 SA-EF1a-scFv-CD28-41BB-CD3ζ | Lentiviral vector | |||
XS-1122-YF712 | Anti-MUC3A KIR CAR (scFv-KIR2DS2-DAP12, XW-712), pCDCAR1 | Human | XW-712 | Mouse | scFv-KIR2DS2 TM&ICD-2A-DAP12 | Lentiviral vector | T Cell | ||
XS-1122-YF713 | Anti-MUC3A KIR CAR (scFv-KIR2DS2-DAP12, XW-713), pCDCAR1 | Human | XW-713 | Human | scFv-KIR2DS2 TM&ICD-2A-DAP12 | Lentiviral vector | T Cell |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION